Pathogenesis and management of metabolic acidosis and alkalosis

Renal and Electrolyte Disorders: Seventh Edition

Volumn , Issue , 2012, Pages 86-121

  Ratnam, Shobha ^a   Kaehny, William D ^b   Shapiro, Joseph I ^a,c  

^a MEDICAL COLLEGE OF OHIO   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c UNIVERSITY OF TOLEDO MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84974605027     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (193)

1. Filley G. Acid-Base and Blood Gas Regulation. Philadelphia: Lea and Febiger; 1971
2. Stewart P, ed. How to Understand Acid-Base. A Quantitative Acid-Base Primer for Biology and Medicine. New York: Elsevier; 1981
3. Alpern R, Warnock D, Rector F. Renal acidification mechanisms. In: Brenner B, Rector F, eds. The Kidney. Philadelphia: WB Saunders; 1986: 206-250
4. Nelson D, Cox M, eds. Lehninger Principles of Biochemistry. 5th ed. New York: W.H. Freeman and Company/Worth Publishers; 2009
5. Srivastava J, Barber DL, Jacobson MP. Intracellular pH sensors: design principles and functional significance. Physiology (Bethesda). 2007;22:30-39
6. Malhotra D, Shapiro J. Nuclear magnetic resonance measurements of intracellular pH: biomedical implications. Concepts Magn Reson. 1993;5:123-150
7. Koo MK, Oh CH, Holme AL, et al. Simultaneous analysis of steady-state intracellular pH and cell morphology by automated laser scanning cytometry. Cytometry A. 2007;71(2):87-93
8. Hille C, Berg M, Bressel L, et al. Time-domain fluorescence lifetime imaging for intracellular pH sensing in living tissues. Anal Bioanal Chem. 2008;391(5):1871-1879
9. Berg J, Tymoczko J, Stryer L, eds. Biochemistry. 6th ed. New York: W.H. Freeman; 2002
10. Adrogue HE, Adrogue HJ. Acid-base physiology. Respir Care. 2001;46(4):328-341
11. Venkatasen J, Hamilton R, Shapiro J. Dialysis considerations in the patient with chronic renal failure. In: Henrich W, ed. Hemodialysis: Principles and Practice. New York: Mosby; 1998
12. Crapo RO, Jensen RL, Hegewald M, et al. Arterial blood gas reference values for sea level and an altitude of 1,400 meters. Am J Respir Crit Care Med. 1999;160(5 pt 1):1525-1531
13. Vasuvattakul S, Warner LC, Halperin ML. Quantitative role of the intracellular bicarbonate buffer system in response to an acute acid load. Am J Physiol. 1992;262(2 pt 2):R305-R309
14. Watts BA 3rd, George T, Good DW. The basolateral NHE1 Na H exchanger regulates transepithelial HCO3 absorption through actin cytoskeleton remodeling in renal thick ascending limb. J Biol Chem. 2005;280(12):11439-11447.
15. Zhang J, Bobulescu IA, Goyal S, et al. Characterization of Na H exchanger NHE8 in cultured renal epithelial cells. Am J Physiol Renal Physiol. 2007;293(3):F761-F766.
16. Vachon V, Delisle MC, Giroux S, et al. Factors affecting the stability of the renal sodium phosphate symporter during its solubilization and reconstitution. Int J Biochem Cell Biol. 1995;27(3):311-318.
17. Paillard M. Na H exchanger subtypes in the renal tubule: function and regulation in physiology and disease. Exp Nephrol. 1997;5(4):277-284
18. Biemesderfer D, Pizzonia J, Abu-Alfa A, et al. NHE3: a Na H exchanger isoform of renal brush border. Am J Physiol. 1993;265(5 pt 2):F736-F742.
19. Loffing J, Lötscher M, Kaissling B, et al. Renal Na/H exchanger NHE-3 and Na-PO4 cotrans-porter NaPi-2 protein expression in glucocorticoid excess and deficient states. J Am Soc Nephrol. 1998;9(9):1560-1567.
20. Xiao YT, Xiang LX, Shao JZ. Vacuolar H()ATPase. Int J Biochem Cell Biol. 2008;40(10):2002-2006.
21. Cougnon M, Bouyer P, Planelles G, et al. Does the colonic H, K-ATPase also act as an Na, K-ATPase?Proc Natl Acad Sci U S A. 1998;95(11): 6516-6520.
22. Suzuki Y, Watanabe T, Kaneko K. A novel H, K()-ATPase in the colonic apical membrane? Jpn J Physiol. 1993;43(3):291-298.
23. Simpson AM, Schwartz GJ. Distal renal tubular acidosis with severe hypokalaemia, probably caused by colonic H()-K()-ATPase deficiency. Arch Dis Child. 2001;84(6):504-507.
24. Wall SM, Truong AV, DuBose TD Jr. H()-K()ATPase mediates net acid secretion in rat terminal inner medullary collecting duct. Am J Physiol. 1996;271(5 pt 2):F1037-F1044.
25. Olsnes S, Ludt J, Tønnessen TI, et al. Bicarbonate chloride antiport in Vero cells: II. Mechanisms for bicarbonate-dependent regulation of intracellular pH. J Cell Physiol. 1987;132(2):192-202
26. Geibel JP. Distal tubule acidification. J Nephrol. 2006;19(suppl 9):S18-S26.
27. HalperinML.Howmuch"new"bicarbonateis formedinthedistalnephronintheprocessofnet acid excretion?KidneyInt. 1989;35(6):1277-12781.
28. Kamel KS, Briceno LF, Sanchez MI, et al. A new classification for renal defects in net acid excretion. Am J Kidney Dis. 1997;29(1):136-146.
29. Weiner ID, Hamm LL. Molecular mechanisms of renal ammonia transport. Annu Rev Physiol. 2007;69:317-340.
30. DuBose TD Jr, Good DW, Hamm LL, et al. Ammonium transport in the kidney: new physiological concepts and their clinical implications. J Am Soc Nephrol. 1991;1:1193-1203.
31. Batlle DC, Hizon M, Cohen E, et al. The use of the urinary anion gap in the diagnosis of hyper-chloremic metabolic acidosis. N Engl J Med. 1988;318(10):594-599.
32. Haussinger D. Liver regulation of acid-base balance. Miner Electrolyte Metab. 1997;23(3-6):249-252.
33. Lardner AL, O'Donovan DJ. Alterations in renal and hepatic nitrogen metabolism in rats during HCl ingestion. Metabolism. 1998;47(2):163-167.
34. Watford M, Chellaraj V, Ismat A, et al. Hepatic glutamine metabolism. Nutrition. 2002;18(4):301-303.
35. Parsa MH, Habif DV, Ferrer JM, et al. Intravenous hyperalimentation: indications, technique, and complications. Bull N Y Acad Med. 1972;48(7):920-942.
36. Oh MS, Carroll HJ. The anion gap. N Engl J Med. 1977;297(15):814-817.
37. Schwartz WB, Orning KJ, Porter R. The internal distribution of hydrogen ions with varying degrees of metabolic acidosis. J Clin Invest. 1957;36(3):373-382.
38. Lemann J Jr, Litzow JR, Lennon EJ. The effects of chronic acid loads in normal man: further evidence for the participation of bone mineral in the defense against chronic metabolic acidosis. J Clin Invest. 1966;45:1608-1617.
39. Burnell J. Changes in bone sodium and carbonate in metabolic acidosis and alkalosis. J Clin Invest. 1971;50:327-335.
40. Cunningham J, Fraher LJ, Clemens TL, et al. Chronic acidosis with metabolic bone disease. Effect of alkali on bone morphology and vitamin D metabolism. Am J Med. 1982;73(2):199-204.
41. Elkinton JR. Clinical disorders of acid-base regulation. A survey of seventeen years' diagnostic experience. Med Clin North Am. 1966;50(5):1325-1350.
42. Fencl V, Miller TB, Pappenheimer JR. Studies on the respiratory response to disturbances of acid-base balance, with deductions concerning the ionic composition of cerebral interstitial fluid. Am J Physiol. 1966;210(3):459-472.
43. Wiederseiner J-M, Muser J, Lutz T, et al. Acute metabolic acidosis: characterization and diagnosis of the disorder and the plasma potassium response. J Am Soc Nephrol. 2004;15:1589-1596.
44. Curthoys NP, Gstraunthaler G. Mechanism of increased renal gene expression during metabolic acidosis. Am J Physiol Renal Physiol. 2001;281(3):F381-F390.
45. Laghmani K, Preisig PA, Moe OW, et al. Endothelin-1/endothelin-B receptor-mediated increases in NHE3 activity in chronic metabolic acidosis. J Clin Invest. 2001;107(12):1563-1569.
46. Madias NE, Schwartz WB, Cohen JJ. The mal-adaptive renal response to secondary hypocapnia during chronic HCl acidosis in the dog. J Clin Invest. 1977;60(6):1393-1401.
47. Shapiro JI, Whalen M, Chan L. Hemodynamic and hepatic pH responses to sodium bicarbonate and Carbicarb during systemic acidosis. Magn Reson Med. 1990;16(3):403-410.
48. O'Brodovich HM, Stalcup SA, Pang LM, et al. Hemodynamic and vasoactive mediator response to experimental respiratory failure. J Appl Physiol. 1982;52(5):1230-1236.
49. Nimmo AJ, Than N, Orchard CH, et al. The effect of acidosis on beta-adrenergic receptors in ferret cardiac muscle. Exp Physiol. 1993;78(1):95-103.
50. Davies AO. Rapid desensitization and uncoupling of human beta-adrenergic receptors in an in vitro model of lactic acidosis. J Clin Endocrinol Metab. 1984;59(3):398-405.
51. Orchard C. The effect of acidosis on excitation-contraction coupling in isolated ferret heart muscle. Mol Cell Biochem. 1989;89(2): 169-173.
52. Allen DG, Orchard CH. The effects of changes of pH on intracellular calcium transients in mammalian cardiac muscle. J Physiol. 1983;335:555-567.
53. Endoh M. Acidic pH-induced contractile dysfunction via downstream mechanism: identification of pH-sensitive domain in troponin. I. J Mol Cell Cardiol. 2001;33(7):1297-1300.
54. Nosek TM, Fender KY, Godt RE. It is diprotonated inorganic phosphate that depresses force in skinned skeletal muscle fibers. Science. 1987;236(4798):191-193.
55. Zhou HZ, Malhotra D, Shapiro JI. Contractile dysfunction during metabolic acidosis: role of impaired energy metabolism. Am J Physiol. 1991;261(5 pt 2):H1481-H1486.
56. Suleymanlar G, Zhou HZ, McCormack M, et al. Mechanism of impaired energy metabolism during acidosis: role of oxidative metabolism. Am J Physiol. 1992;262(6 pt 2):H1818-H1822.
57. Zhou HZ, Malhotra D, Doers J, et al. Hypoxia and metabolic acidosis in the isolated heart: evidence for synergistic injury. Magn Reson Med. 1993;29(1):94-98.
58. McGillivray-Anderson KM, Faber JE. Effect of acidosis on contraction of microvascular smooth muscle by alpha 1-and alpha 2-adrenoceptors. Implications for neural and metabolic regulation. Circ Res. 1990;66(6):1643-1657.
59. Verdon F. Respiratory response to acute metabolic acidosis in man. Intensive Care Med. 1979;5(4):204.
60. Janusek LW. Metabolic acidosis: pathophysiology, signs, and symptoms. Nursing. 1990;20(7):52-53.
61. Bushinsky DA, Parker WR, Alexander KM, et al. Metabolic, but not respiratory, acidosis increases bone PGE(2) levels and calcium release. Am J Physiol Renal Physiol. 2001;281(6):F1058-F1066.
62. Adrogue HJ, Madias NE. Changes in plasma potassium concentration during acute acid-base disturbances. Am J Med. 1981;71(3):456-467.
63. Emmett M, Narins RG. Clinical use of the anion gap. Medicine (Baltimore). 1977;56(1):38-54.
64. Gabow PA, Kaehny WD, Fennessey PV, et al. Diagnostic importance of an increased serum anion gap. N Engl J Med. 1980;303(15):854-858.
65. Streather CP, Phillips AO, Goodman FR, et al. How often should we measure the urinary anion gap for cases of suspected renal tubular acidosis?Nephrol Dial Transplant. 1993;8(6):571.
66. Wang F, Butler T, Rabbani GH, et al. The acidosis of cholera. Contributions of hyperproteinemia, lactic acidemia, and hyperphosphatemia to an increased serum anion gap. N Engl J Med. 1986;315(25):1591-1595.
67. Gennari FJ, Weise WJ. Acid-base disturbances in gastrointestinal disease. Clin J Am Soc Nephrol. 2008;3:1861-1868.
68. Margolis A, Dziatkowiak H, Bugala I, et al. Urine acidification ability in infants. II. Urinary excretion of hydrogen ions in infants with diarrhea and chronic metabolic acidosis. Pediatr Pol. 1972;47(8):979-983.
69. Phillips SF. Water and electrolytes in gastrointestinal disease. In: Maxwell MH, Kleeman CR, eds. Clinical Disorders of Fluid and Electrolyte Metabolism. New York: McGraw-Hill; 1980:1267-1295.
70. Nathan DM, Fogel H, Norman D, et al. Long-term metabolic and quality of life results with pancreatic renal transplantation in insulin-dependent diabetes mellitus. Transplantation. 1991;52(1):85-91.
71. Ketel B, Henry ML, Elkhammas EA, et al. Metabolic complications in combined kidney/pancreas transplantation. Transplant Proc. 1992;24(3):774-775.
72. Tom WW, Munda R, First MR, et al. Physiologic consequences of pancreatic allograft exocrine drainage into the urinary tract. Transplant Proc. 1987;19(1 pt 3):2339-2342.
73. Monroy-Cuadros M, Salazar A, Yilmaz S, et al. Bladder vs enteric drainage in simultaneous pancreas-kidney transplantation. Nephrol Dial Transplant. 2006;21(2):483-487.
74. Mills RD, Studer UE. Metabolic consequences of continent urinary diversion. J Urol. 1999;161(4):1057-1066.
75. Hautmann RE, de Petriconi R, Gottfried HW, et al. The ileal neobladder: complications and functional results in 363 patients after 11 years of followup. J Urol. 1999;161(2):422-427; discussion 427-428.
76. Thompson WG. Cholestyramine. Can Med Assoc J. 1971;104(4):305-309.
77. Scheel PJ Jr, Whelton A, Rossiter K, et al. Cholestyramine-induced hyperchloremic metabolic acidosis. J Clin Pharmacol. 1992;32(6):536-538.
78. Haldane JB, Hill R, Luck JM. Calcium chloride acidosis. J Physiol. 1923;57(5):301-306.
79. Lash JP, Arruda JA. Laboratory evaluation of renal tubular acidosis. Clin Lab Med. 1993;13(1):117-129.
80. Batlle D, Moorthi KM, Schlueter W, et al. Distal renal tubular acidosis and the potassium enigma. Semin Nephrol. 2006;26(6):471-478.
81. Karet FE. Mechanisms in hyperkalemic renal tubular acidosis. J Am Soc Nephrol. 2009;20(2):251-254.
82. Quigley R. Proximal renal tubular acidosis. J Nephrol. 2006;19(suppl 9):S41-S45.
83. Igarashi T, Sekine T, Inatomi J, et al. Unraveling the molecular pathogenesis of isolated proximal renal tubular acidosis. J Am Soc Nephrol. 2002;13(8):2171-2177.
84. Izzedine H, Launay-Vacher V, Isnard-Bagnis C, et al. Drug-induced Fanconi's syndrome. Am J Kidney Dis. 2003;41(2):292-309.
85. Clarke BL, Wynne AG, Wilson DM, et al. Osteomalacia associated with adult Fanconi's syndrome: clinical and diagnostic features. Clin Endocrinol (Oxf). 1995;43(4):479-490.
86. McSherry E. Renal tubular acidosis in childhood. Kidney Int. 1981;20(6):799-809.
87. Vasuvattakul S, Nimmannit S, Shayakul C, et al. Should the urine PCO2 or the rate of excretion of ammonium be the gold standard to diagnose distal renal tubular acidosis? Am J Kidney Dis. 1992;19(1):72-75.
88. Richardson RM, Halperin ML. The urine pH: a potentially misleading diagnostic test in patients with hyperchloremic metabolic acidosis. Am J Kidney Dis. 1987;10(2):140-143.
89. Jefferies KC, Cipriano DJ, Forgac M. Function, structure and regulation of the vacuolar (H)ATPases. Arch Biochem Biophys. 2008;476(1):33-42.
90. Fuster DG, Zhang J, Xie XS, et al. The vacuolarATPase B1 subunit in distal tubular acidosis: novel mutations and mechanisms for dysfunction. Kidney Int. 2008;73(10):1151-1158.
91. Walsh SB, Shirley DG, Wrong OM, et al. Urinary acidification assessed by simultaneous furosemide and fludrocortisone treatment: an alternative to ammonium chloride. Kidney Int. 2007;71(12):1310-1316.
92. Ren H, Wang WM, Chen XN, et al. Renal involvement and followup of 130 patients with primary Sjogren's syndrome. J Rheumatol. 2008;35(2):278-284.
93. D'Cruz S, Chauhan S, Singh R, et al. Wasp sting associated with type 1 renal tubular acidosis. Nephrol Dial Transplant. 2008;23(5):1754-1755.
94. Kamijima M, Nakazawa Y, Yamakawa M, et al. Metabolic acidosis and renal tubular injury due to pure toluene inhalation. Arch Environ Health. 1994;49(5):410-413.
95. Batlle DC, Arruda JA, Kurtzman NA. Hyperkalemic distal renal tubular acidosis associated with obstructive uropathy. N Engl J Med. 1981;304(7):373-380.
96. Sharma AP, Sharma RK, Kapoor R, et al. Incomplete distal renal tubular acidosis affects growth in children. Nephrol Dial Transplant. 2007;22(10):2879-2885.
97. DuBose TD Jr. Carbonic anhydrase-dependent bicarbonate transport in the kidney. Ann N Y Acad Sci. 1984;429:528-537.
98. Groeper K, McCann ME. Topiramate and metabolic acidosis: a case series and review of the literature. Paediatr Anaesth. 2005;15(2):167-170.
99. Welch BJ, Graybeal D, Moe OW, et al. Biochemical and stone-risk profiles with topiramate treatment. Am J Kidney Dis. 2006;48(4):555-563.
100. Kurtzman NA, Gonzalez J, DeFronzo R, et al. A patient with hyperkalemia and metabolic acidosis. Am J Kidney Dis. 1990;15(4):333-356.
101. DeFronzo RA. Hyperkalemia and hyporeninemic hypoaldosteronism. Kidney Int. 1980;17(1):118-134.
102. Allen GG, Barratt LJ. An in vivo study of voltage-dependent renal tubular acidosis induced by amiloride. Kidney Int. 1989;35(5):1107-1110.
103. Garty H, Benos DJ. Characteristics and regulatory mechanisms of the amiloride-blockable Na+channel. Physiol Rev. 1988;68(2):309-373.
104. Effectiveness of spironolactone added to an angiotensin-converting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failure (the Randomized Aldactone Evaluation Study [RALES]). Am J Cardiol. 1996;78(8):902-907.
105. Witham MD, Gillespie ND, Struthers AD. Hyperkalemia after the publication of RALES. N Engl J Med. 2004;351(23):2448-2450; author reply 2448-2450.
106. Adrogue HJ, Wilson H, Boyd AE 3rd, et al. Plasma acid-base patterns in diabetic ketoacidosis. N Engl J Med. 1982;307(26):1603-1610.
107. Gowrishankar M, Carlotti AP, St George-Hyslop C, et al. Uncovering the basis of a severe degree of acidemia in a patient with diabetic ketoacidosis. QJM. 2007;100(11):721-735.
108. Garella S, Chang BS, Kahn SI. Dilution acidosis and contraction alkalosis: review of a concept. Kidney Int. 1975;8(5):279-283.
109. Relman AS, Shelburne PF, Talman A. Profound acidosis resulting from excessive ammonium chloride in previously healthy subjects. A study of two cases. N Engl J Med. 1961;264:848-852.
110. Heird WC, Dell RB, Driscoll JM Jr, et al. Metabolic acidosis resulting from intravenous alimentation mixtures containing synthetic amino acids. N Engl J Med. 1972;287(19):943-948.
111. Lemann J Jr, Relman AS. The relation of sulfur metabolism to acid-base balance and electrolyte excretion: the effects of DL-methionine in normal man. J Clin Invest. 1959;38:2215-2223.
112. Madias NE. Lactic acidosis. Kidney Int. 1986;29(3):752-774.
113. Malhotra D, Shapiro JI, Chan L. Nuclear magnetic resonance spectroscopy in patients with anion-gap acidosis. J Am Soc Nephrol. 1991;2(5):1046-1050.
114. Oh MS, Phelps KR, Traube M, et al. D-Lactic acidosis in a man with the short-bowel syndrome. N Engl J Med. 1979;301(5):249-252.
115. Cooper DJ, Walley KR, Wiggs BR, et al. Bicarbonate does not improve hemodynamics in critically ill patients who have lactic acidosis. A prospective, controlled clinical study. Ann Intern Med. 1990;112(7):492-498.
116. Graf H, Leach W, Arieff AI. Evidence for a detrimental effect of bicarbonate therapy in hypoxic lactic acidosis. Science. 1985;227(4688):754-756.
117. Graf H, Leach W, Arieff AI. Metabolic effects of sodium bicarbonate in hypoxic lactic acidosis in dogs. Am J Physiol. 1985;249(5 pt 2):F630-F635.
118. Huntley JJ, McCormack M, Jin H, et al. Importance of tonicity of carbicarb on the functional and metabolic responses of the acidotic isolated heart. J Crit Care. 1993;8(4):222-227.
119. Adrogue HJ, Madias NE. Management of life-threatening acid-base disorders. First of two parts. N Engl J Med. 1998;338(1):26-34.
120. Westphal SA. The occurrence of diabetic ketoacidosis in non-insulin-dependent diabetes and newly diagnosed diabetic adults. Am J Med. 1996;101(1):19-24.
121. Filbin MR, Brown DF, Nadel ES. Hyperglycemic hyperosmolar nonketotic coma. J Emerg Med. 2001;20(3):285-290.
122. Oh MS, Carroll HJ, Goldstein DA, et al. Hyperchloremic acidosis during the recovery phase of diabetic ketosis. Ann Intern Med. 1978;89(6):925-927.
123. Gabow PA, Anderson RJ, Potts DE, et al. Acid-base disturbances in the salicylate-intoxicated adult. Arch Intern Med. 1978;138:1481-1484.
124. Lee P, Campbell LV. Diabetic ketoacidosis: the usual villain or a scapegoat? A novel cause of severe metabolic acidosis in type 1 diabetes. Diabetes Care. 2008;31(3):e13.
125. Soler NG, Bennett MA, Dixon K, et al. Potassium balance during treatment of diabetic ketoacidosis with special reference to the use of bicarbonate. Lancet. 1972;2(7779):665-667.
126. Kaye R. Diabetic ketoacidosis-the bicarbonate controversy. J Pediatr. 1975;87(1):156-159.
127. Sabatini S, Kurtzman NA. Bicarbonate therapy in severe metabolic acidosis. J Am Soc Nephrol. 2009;20(4):692-695.
128. Stinebaugh BJ, Schloeder FX. Glucose-induced alkalosis in fasting subjects. Relationship to renal bicarbonate reabsorption during fasting and refeeding. J Clin Invest. 1972;51(6):1326-1336.
129. Yanagawa Y, Sakamoto T, Okada Y. Six cases of sudden cardiac arrest in alcoholic ketoacidosis. Intern Med. 2008;47(2):113-117.
130. Godet C, Hira M, Adoun M, et al. Rapid diagnosis of alcoholic ketoacidosis by proton NMR. Intensive Care Med. 2001;27(4):785-786.
131. Halperin ML, Hammeke M, Josse RG, et al. Metabolic acidosis in the alcoholic: a pathophysiologic approach. Metabolism. 1983;32(3):308-315.
132. Arieff AI, Carroll HJ. Nonketotic hyperosmolar coma with hyperglycemia: clinical features, pathophysiology, renal function, acid-base balance, plasma-cerebrospinal fluid equilibria and the effects of therapy in 37 cases. Medicine (Baltimore). 1972;51(2):73-94.
133. Arieff AI, Carroll HJ. Hyperosmolar nonketotic coma with hyperglycemia: abnormalities of lipid and carbohydrate metabolism. Metabolism. 1971;20(6):529-538.
134. Halperin ML. Metabolism and acid-base physiology. Artif Organs. 1982;6(4):357-362.
135. Gabow PA. Ethylene glycol intoxication. Am J Kidney Dis. 1988;11(3):277-279.
136. Gabow PA, Clay K, Sullivan JB, et al. Organic acids in ethylene glycol intoxication. Ann Intern Med. 1986;105(1):16-20.
137. McMartin KE, Ambre JJ, Tephly TR. Methanol poisoning in human subjects. Role for formic acid accumulation in the metabolic acidosis. Am J Med. 1980;68(3):414-418.
138. Schelling JR, Howard RL, Winter SD, et al. Increased osmolal gap in alcoholic ketoacidosis and lactic acidosis. Ann Intern Med. 1990;113(8):580-582.
139. Sklar AH, Linas SL. The osmolal gap in renal failure. Ann Intern Med. 1983;98(4):481-482.
140. Streicher HZ, Gabow PA, Moss AH, et al. Syndromes of toluene sniffing in adults. Ann Intern Med. 1981;94(6):758-762.
141. Pomara C, Fiore C, D'Errico S, et al. Calcium oxalate crystals in acute ethylene glycol poisoning: a confocal laser scanning microscope study in a fatal case. Clin Toxicol (Phila). 2008;46(4):322-324.
142. Jacobsen D, Hewlett TP, Webb R, et al. Ethylene glycol intoxication: evaluation of kinetics and crystalluria. Am J Med. 1988;84(1):145-152.
143. Kraut JA, Kurtz I. Toxic alcohol ingestions: clinical features, diagnosis, and management. Clin J Am Soc Nephrol. 2008;3(1):208-225.
144. Hill JB. Salicylate intoxication. N Engl J Med. 1973;288(21):1110-1113.
145. Rivera W, Kleinschmidt KC, Velez LI, et al. Delayed salicylate toxicity at 35 hours without early manifestations following a single salicylate ingestion. Ann Pharmacother. 2004;38(7 8):1186-1188.
146. Gordon IJ, Bowler CS, Coakley J, et al. Algorithm for modified alkaline diuresis in salicylate poisoning. Br Med J (Clin Res Ed). 1984;289(6451):1039-1040.
147. Lund B, Seifert SA, Mayersohn M. Efficacy of sustained low-efficiency dialysis in the treatment of salicylate toxicity. Nephrol Dial Transplant. 2005;20(7):1483-1484.
148. Wong LP, Klemmer PJ. Severe lactic acidosis associated with juice of the mangosteen fruit Garcinia mangostana. Am J Kidney Dis. 2008;51(5): 829-833.
149. Fodale V, La Monaca E. Propofol infusion syndrome: an overview of a perplexing disease. Drug Saf. 2008;31(4):293-303.
150. Zar T, Yusufzai I, Sullivan A, et al. Acute kidney injury, hyperosmolality and metabolic acidosis associated with lorazepam. Nat Clin Pract Nephrol. 2007;3(9):515-520.
151. Pitt JJ, Hauser S. Transient 5-oxoprolinuria and high anion gap metabolic acidosis: clinical and biochemical findings in eleven subjects. Clin Chem. 1998;44:1497-1503.
152. Tailor P, Raman T, Garganta CL, et al. Recurrent high anion gap metabolic acidosis secondary to 5-oxoproline (pyroglutamic acid). Am J Kidney Dis. 2005;46:E4-E10.
153. Batlle DC, Sabatini S, Kurtzman NA. On the mechanism of toluene-induced renal tubular acidosis. Nephron. 1988;49(3):210-218.
154. DeMars CS, Hollister K, Tomassoni A, et al. Citric acid ingestion: a life-threatening cause of metabolic acidosis. Ann Emerg Med. 2001;38(5):588-591.
155. Widmer B, Gerhardt RE, Harrington JT, et al. Serum electrolyte and acid base composition. The influence of graded degrees of chronic renal failure. Arch Intern Med. 1979;139(10):1099-1102.
156. Halperin ML, Ethier JH, Kamel KS. Ammonium excretion in chronic metabolic acidosis: benefits and risks. Am J Kidney Dis. 1989;14(4):267-271.
157. Molitoris BA, Froment DH, Mackenzie TA, et al. Citrate: a major factor in the toxicity of orally administered aluminum compounds. Kidney Int. 1989;36(6):949-953.
158. Kette F, Weil MH, von Planta M, et al. Buffer agents do not reverse intramyocardial acidosis during cardiac resuscitation. Circulation. 1990;81(5):1660-1666.
159. Barenbrock M, Hausberg M, Matzkies F, et al. Effects of bicarbonate-and lactate-buffered replacement fluids on cardiovascular outcome in CVVH patients. Kidney Int. 2000;58(4):1751-1757.
160. Gudis SM, Mangi S, Feinroth M, et al. Rapid correction of severe lactic acidosis with massive isotonic bicarbonate infusion and simultaneous ultrafiltration. Nephron. 1983;33(1):65-66.
161. Giunti C, Priouzeau F, Allemand D, et al. Effect of tris-hydroxymethyl aminomethane on intracellular pH depends on the extracellular non-bicarbonate buffering capacity. Transl Res. 2007;150(6):350-356.
162. Stacpoole PW, Gilbert LR, Neiberger RE, et al. Evaluation of long-term treatment of children with congenital lactic acidosis with dichloroacetate. Pediatrics. 2008;121(5):e1223-e1228.
163. Galla JH. Metabolic alkalosis. J Am Soc Nephrol. 2000;11(2):369-375.
164. Adam WR, Craik DJ, Kneen M, et al. Effect of magnesium depletion and potassium depletion and chlorothiazide on intracellular pH in the rat, studied by 31P NMR. Clin Exp Pharmacol Physiol. 1989;16(1):33-40.
165. Palmer BF. Approach to fluid and electrolyte disorders and acid-base problems. Prim Care. 2008;35(2):195-213, v.
166. Shapiro JI, Anderson RJ. Sodium depletion states. In: Brenner BM, Stein J, eds. Topics in Nephrology. New York: Churchill Livingstone; 1985:155-192.
167. Kassirer JP, Berkman PM, Lawrenz DR, et al. The critical role of chloride in the correction of hypokalemic alkalosis in man. Am J Med. 1965;38:172-189.
168. Melby JC. Assessment of adrenocortical function. N Engl J Med. 1971;285(13):735-739.
169. Garella S, Chazan JA, Cohen JJ. Saline-resistant metabolic alkalosis or "chloride-wasting nephropathy". Report of four patients with severe potassium depletion. Ann Intern Med. 1970;73(1):31-38.
170. Adam WR, Koretsky AP, Weiner MW. Measurement of renal intracellular pH by 31P NMR. Relationship of pH to ammoniagenesis. Contrib Nephrol. 1985;47:15-21.
171. Kassirer JP, Schwartz WB. Correction of metabolic alkalosis in man without repair of potassium deficiency. A re-evaluation of the role of potassium. Am J Med. 1966;40(1):19-26.
172. Lucci MS, Tinker JP, Weiner IM, et al. Function of proximal tubule carbonic anhydrase defined by selective inhibition. Am J Physiol. 1983;245(4):F443-F449.
173. Madias NE, Ayus JC, Adrogue HJ. Increased anion gap in metabolic alkalosis: the role of plasma-protein equivalency. N Engl J Med. 1979;300(25):1421-1423.
174. Kassirer JP, Schwartz WB. The response of normal man to selective depletion of hydrochloric acid. Factors in the genesis of persistent gastric alkalosis. Am J Med. 1966;40(1):10-18.
175. Jurgeleit HC. Villous adenoma of the colon with severe fluid and electrolyte depletion: report of a case. Dis Colon Rectum. 1976;19(5):445-447.
176. Jamison RL, Ross JC, Kempson RL, et al. Surreptitious diuretic ingestion and pseudo-Bartter's syndrome. Am J Med. 1982;73(1):142-147.
177. Brackett NC Jr, Wingo CF, Muren O, et al. Acid-base response to chronic hypercapnia in man. N Engl J Med. 1969;280(3):124-130.
178. Fustik S, Pop-Jordanova N, Slaveska N, et al. Metabolic alkalosis with hypoelectrolytemia in infants with cystic fibrosis. Pediatr Int. 2002;44(3):289-292.
179. Kassirer JP, London AM, Goldman DM, et al. On the pathogenesis of metabolic alkalosis in hyperaldosteronism. Am J Med. 1970;49(3):306-315.
180. Dluhy RG, Lifton RP. Glucocorticoid-remediable aldosteronism. J Clin Endocrinol Metab. 1999;84(12):4341-4344.
181. Bartter FC, Pronove P, Gill JR Jr, et al. Hyperplasia of the juxtaglomerular complex with hyperaldosteronism and hypokalemic alkalosis. A new syndrome. Am J Med. 1962;33:811-828.
182. Bartter FC. So-called Bartter's syndrome. N Engl J Med. 1969;281(26):1483-1484.
183. Simon DB, Karet FE, Hamdan JM, et al. Bartter's syndrome, hypokalaemic alkalosis with hypercalciuria, is caused by mutations in the Na-K-2Cl cotransporter NKCC2. Nat Genet. 1996;13(2):183-188.
184. Simon DB, Karet FE, Rodriguez-Soriano J, et al. Genetic heterogeneity of Bartter's syndrome revealed by mutations in the K channel, ROMK. Nat Genet. 1996;14(2):152-156.
185. Simon DB, Bindra RS, Mansfield TA, et al. Mutations in the chloride channel gene, CLCNKB, cause Bartter's syndrome type III. Nat Genet. 1997;17(2):171-178.
186. Simon DB, Nelson-Williams C, Bia MJ, et al. Gitelman's variant of Bartter's syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotrans-porter. Nat Genet. 1996;12(1):24-30.
187. Armanini D, Scali M, Zennaro MC, et al. The pathogenesis of pseudohyperaldosteronism from carbenoxolone. J Endocrinol Invest. 1989;12(5):337-341.
188. Rahilly GT, Berl T. Severe metabolic alkalosis caused by administration of plasma protein fraction in end-stage renal failure. N Engl J Med. 1979;301(15):824-826.
189. Orwoll ES. The milk-alkali syndrome: current concepts. Ann Intern Med. 1982;97(2):242-248.
190. Heinemann HO. Metabolic alkalosis in patients with hypercalcemia. Metabolism. 1965;14(11):1137-1152.
191. Lipner HI, Ruzany F, Dasgupta M, et al. The behavior of carbenicillin as a nonreabsorbable anion. J Lab Clin Med. 1975;86(2):183-194.
192. Morrison RS. Management of emergencies. 8. Metabolic acidosis and alkalosis. N Engl J Med. 1966;274(21):1195-1197.
193. Barton CH, Vaziri ND, Ness RL, et al. Cimetidine in the management of metabolic alkalosis induced by nasogastric drainage. Arch Surg. 1979;114(1):70-74.